发明名称 |
Acylated glucagon analogues |
摘要 |
The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel acylated glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon. |
申请公布号 |
AU2014336098(A1) |
申请公布日期 |
2016.04.21 |
申请号 |
AU20140336098 |
申请日期 |
2014.10.17 |
申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH;ZEALAND PHARMA A/S |
发明人 |
RIBER, DITTE;TOLBORG, JAKOB LIND;HAMPRECHT, DIETER WOLFGANG;RIST, WOLFGANG |
分类号 |
C07K14/605;A61K38/26 |
主分类号 |
C07K14/605 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|